Skip to Content

'
Ara A. Vaporciyan, M.D., F.A.C.S., MHPE

Present Title & Affiliation

Primary Appointment

Professor, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Dual/Joint/Adjunct Appointment

Deputy Chair, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX

Office Address

The University of Texas MD Anderson Cancer Center
1515 Holcombe Blvd.
Box 1489
Houston, TX 77030
Room Number: FCT19.6008
Phone: (713) 745-4533
Fax: (713) 794-4901

Education & Training

Postgraduate Training

7/1996-6/1998 Resident, Cardiothoracic Surgery, The University of Texas MD Anderson Cancer Center/Texas Heart Institute, Houston
7/1993-6/1996 Resident, General Surgery, The University of Texas Medical School at Houston, Houston
7/1991-6/1993 Postdoctoral Fellowship, Department of Pathology, University of Michigan Medical School, Ann Arbor
7/1989-6/1991 Intern and Resident, General Surgery, The University of Texas Medical School at Houston, Houston

Board Certifications

6/1999 Diplomat, American Board of Thoracic Surgery
6/1997 Diplomat, American Board of Surgery

Experience/Service

Academic Appointments

Associate Professor, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 9/2004-8/2010
Assistant Professor, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 1/1998-1/2004

Administrative Appointments/Responsibilities

Disease-Site Liaison, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, TX, 7/2007-present
Member, Faculty Senate, The University of Texas MD Anderson Cancer Center, Houston, 1/2005-present
Rotating Program Coordinator, Thoracic & Cardiovascular Surgery, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, 1/2003-present
Medical Director, Thoracic & Cardiovascular Surgery Database, Department of Thoracic and Cardiovascular Surgery, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, 1/2003-present
Quality Improvement Officer, The University of Texas MD Anderson Cancer Center, Houston, TX, 1/2003-present
Director, Clinical Education & Training, The University of Texas MD Anderson Cancer Center, Houston, 1/2003-present
Director, Cardiac & Vascular Surgical Oncology Program, The University of Texas MD Anderson Cancer Center, Houston, 1/2002-present

Other Appointments/Responsibilities

Executive Council Member, Joint Council of Thoracic Surgical Education, Chicago, IL, 1/2009-present
Chair, Writing Committee for the CT Interest Survey, AATS & STS Joint Committee, Houston, TX, 6/2008-present
Committee Member, Post-Graduate Course Committee, Southern Thoracic Surgical Association, Houston, TX, 11/2006-present

Institutional Committee Activities

Member, CME Advisory Committee, 10/2008-present
Chair, Clinical Educator Working Group, 4/2008-present
Member, Clinical Research Impact Subcommittee of the Clinical Council, 2006-present
Member, Faculty Senate, 2005-2008
Member, Medical Records Subcommittee, 1/2004-present
Member, Divisional Promotion/Tenure Committee, 1/2004-present
Member, Institutional Review Subcommittee, 1/2003-present
Reviewer, Institutional Review Board, 9/2002-present
Reviewer, Institutional Review Board, 3/2002-present
External Member, Bone Primary and Metastatic Tissue Bank, 1/2002-present
Member, Task Force for Blood Utilization in the Operating Room, 1/2002-1/2003
Member, Task Force ICU Bed Utilization, 1/2002-1/2003
Member, Task Force Cardiac Monitoring/ Telemetry, 1/2002-7/2002
Member, Medical Practice Subcommittee, 1/2001-1/2005

Honors and Awards

2009-present Best Doctors in America, Best Doctors
2006 The Chief Resident Teaching Award, The University of Texas Medical School at Houston, Department of Surgery
2005 Honorary Speaker, Peking University School of Oncology, Beijing Cancer Hospital and Beijing Tuberculosis & Tumor Research Institute
2004 Special Teaching Award, Selected by the Surgical Oncology Fellows, Department of Surgical Oncology, The University of Texas M.D. Anderson Cancer Center
2003 Outstanding Faculty Teaching Award, Baylor College of Medicine Michael E. DeBakey Department of Surgery
2002 The Chief Resident Teaching Award, The University of Texas Medical School at Houston, Department of Surgery
1996 Outstanding Surgical Resident Award, The University of Texas, M. D. Anderson Cancer Center

Professional Memberships

American Association for Thoracic Surgery
Member, 2006-present
American College of Surgeons
Fellow, 2003-present
Cooley Hands
Member, 1996-present
Denton A. Cooley Cardiovascular Surgical Society
Member, 1996-present
General Thoracic Surgical Club
Member, 2005-present
Harris County Medical Society and Texas Medical Association
Member, 2006-present
International Association of Lung Cancer
Member, 1999-present
Society of Thoracic Surgeons
Member, 2003-present
Society of University Surgeons
Member, 2004-present
Southern Thoracic Surgical Association
Member, 2001-present
Thoracic Surgery Directors Association, Chicago, IL
Member, 1/2003-present

Selected Publications

Peer-Reviewed Original Research Articles
1. Lopez Guerra JL, Gomez DR, Lin SH, Levy LB, Zhuang Y, Komaki R, Jaen J, Vaporciyan AA, Swisher SG, Cox JD, Liao Z, Rice DC. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy. Ann Oncol 24(1):67-74, 1/2013. e-Pub 9/2012. PMCID: PMC3525136.
2. Amini A, Lou F, Correa AM, Baldassarre R, Rimner A, Huang J, Roth JA, Swisher SG, Vaporciyan AA, Lin SH. Predictors for Locoregional Recurrence for Clinical Stage III-N2 Non-small Cell Lung Cancer with Nodal Downstaging After Induction Chemotherapy and Surgery. Ann Surg Oncol. e-Pub 12/2012. PMID: 23263700.
3. Blackmon SH, Stephens EH, Correa AM, Hofstetter W, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Walsh GL, Vaporciyan AA. Predictors of recurrent pulmonary metastases and survival after pulmonary metastasectomy for colorectal cancer. Ann Thorac Surg 94(6):1802-9, 12/2012. e-Pub 10/2012. PMID: 23063195.
4. Sepesi B, Swisher SG, Walsh GL, Correa A, Mehran RJ, Rice D, Roth J, Vaporciyan A, Hofstetter WL. Omental reinforcement of the thoracic esophagogastric anastomosis: An analysis of leak and reintervention rates in patients undergoing planned and salvage esophagectomy. J Thorac Cardiovasc Surg 144(5):1146-51, 11/2012. e-Pub 8/2012. PMID: 22939861.
5. Stephens EH, Cornwell LD, Simpson KH, Chu D, Coselli JS, Holman WL, Vaporciyan AA, Merrill WH, Bakaeen FG. Perceptions and expectations of cardiothoracic residents and attending surgeons. J Surg Res 177(2):e45-52, 10/2012. e-Pub 4/17/2012. PMID: 22531676.
6. Marks JL, Hofstetter W, Correa AM, Mehran RJ, Rice D, Roth J, Walsh G, Vaporciyan A, Erasmus J, Chang J, Maru D, Lee JH, Lee J, Ajani JA, Swisher SG. Salvage Esophagectomy After Failed Definitive Chemoradiation for Esophageal Adenocarcinoma. Ann Thorac Surg 94(4):1126-32; discussion 1132-3, 10/2012. e-Pub 8/2012. PMID: 22921233.
7. Blackmon SH, Correa AM, Skoracki R, Chevray PM, Kim MP, Mehran RJ, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Yu P, Walsh GL, Hofstetter WL. Supercharged Pedicled Jejunal Interposition for Esophageal Replacement: A 10-Year Experience. Ann Thorac Surg 94(4):1104-11; discussion 1111-3, 10/2012. e-Pub 8/2012. PMID: 22939245.
8. Kim JY, Hildebrandt MA, Pu X, Ye Y, Correa AM, Vaporciyan AA, Wu X, Roth JA. Variations in the Vascular Endothelial Growth Factor Pathway Predict Pulmonary Complications. Ann Thorac Surg 94(4):1079-84; discussion 1084-5, 10/2012. e-Pub 7/2012. PMCID: PMC3466075.
9. Taketa T, Correa AM, Suzuki A, Blum MA, Chien P, Lee JH, Welsh J, Lin SH, Maru DM, Erasmus JJ, Bhutani MS, Weston B, Rice DC, Vaporciyan AA, Hofstetter WL, Swisher SG, Ajani JA. Outcome of Trimodality-Eligible Esophagogastric Cancer Patients Who Declined Surgery after Preoperative Chemoradiation. Oncology 83(5). e-Pub 9/2012. PMID: 22964903.
10. Amini A, Correa AM, Komaki R, Chang JY, Tsao AS, Roth JA, Swisher SG, Rice DC, Vaporciyan AA, Lin SH. The Role of Consolidation Therapy for Stage III Non-Small Cell Lung Cancer With Persistent N2 Disease After Induction Chemotherapy. Ann Thorac Surg 94(3):914-20, 9/2012. e-Pub 7/2012. PMID: 22819472.
11. Vaporciyan AA. Who will determine the educational needs of our trainees? J Thorac Cardiovasc Surg 144(3):532-3, 9/2012. e-Pub 6/2012. PMID: 22749625.
12. Ajani JA, Correa AM, Hofstetter WL, Rice DC, Blum MA, Suzuki A, Taketa T, Welsh J, Lin SH, Lee JH, Bhutani MS, Ross WA, Maru DM, Macapinlac HA, Erasmus J, Komaki R, Mehran RJ, Vaporciyan AA, Swisher SG. Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer. Ann Oncol. e-Pub 7/2012. PMID: 22831985.
13. Ramlawi B, David EA, Kim MP, Garcia-Morales LJ, Blackmon SH, Rice DC, Vaporciyan AA, Reardon MJ. Contemporary surgical management of cardiac paragangliomas. Ann Thorac Surg 93(6):1972-6, 6/2012. e-Pub 4/2012. PMID: 22537533.
14. Pataer A, Kalhor N, Correa AM, Raso MG, Erasmus JJ, Kim ES, Behrens C, Lee JJ, Roth JA, Stewart DJ, Vaporciyan AA, Wistuba II, Swisher SG, The University of Texas M. D. Anderson Lung Cancer Collaborative Research Group. Histopathologic Response Criteria Predict Survival of Patients with Resected Lung Cancer After Neoadjuvant Chemotherapy. J Thorac Oncol. e-Pub 4/2012. PMID: 22481232.
15. Claiborne PM, Fowler CS, Vaporciyan AA. Follow-up of Patients with Resected Thoracic Malignancies. Thorac Surg Clin 22(1):123-31, 2/2012. e-Pub 10/2011. PMID: 22108696.
16. Harvin JA, Lahat G, Correa AM, Lee J, Maru D, Ajani J, Marom EM, Welsh J, Bhutani MS, Walsh G, Roth J, Mehran R, Vaporciyan A, Rice D, Swisher S, Hofstetter W. Neoadjuvant chemoradiotherapy followed by surgery for esophageal adenocarcinoma: Significance of microscopically positive circumferential radial margins. J Thorac Cardiovasc Surg 143(2):412-20, 2/2012. e-Pub 12/2011. PMID: 22172216.
17. Kim JY, Correa AM, Vaporciyan AA, Roth JA, Mehran RJ, Walsh GL, Rice DC, Ajani JA, Maru DM, Bhutani MS, Welsh J, Marom EM, Swisher SG, Hofstetter WL. Does the Timing of Esophagectomy After Chemoradiation Affect Outcome? Ann Thorac Surg 93(1):207-12; discussion 212-3, 1/2012. e-Pub 10/2011. PMID: 21962263.
18. Wagner KW, Ye Y, Lin J, Vaporciyan AA, Roth JA, Wu X. Genetic variations in epigenetic genes are predictors of recurrence in stage I or II non-small cell lung cancer patients. Clin Cancer Res 18(2):585-92, 1/2012. PMID: 22252258.
19. Pool KL, Munden RF, Vaporciyan A, O'Sullivan PJ. Radiographic imaging features of thoracic complications after pneumonectomy in oncologic patients. Eur J Radiol 81(1):165-72, 1/2012. e-Pub 10/2010. PMID: 20888720.
20. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Mehran RJ, Rice DC, Suzuki A, Lee JH, Bhutani MS, Welsh J, Lin SH, Maru DM, Swisher SG, Ajani JA. Patients with high body mass index tend to have lower stage of esophageal carcinoma at diagnosis. Dis Esophagus. e-Pub 12/2011. PMID: 22150920.
21. Hemmati SH, Correa AM, Walsh GL, Swisher SG, Roth JA, Rice DC, Mehran RJ, Vaporciyan AA. The prognostic factors of chest wall metastasis resection. Eur J Cardiothorac Surg 40(2):328-33, 8/2011. e-Pub 4/2011. PMID: 21466960.
22. Brouquet A, Vauthey JN, Contreras CM, Walsh GL, Vaporciyan AA, Swisher SG, Curley SA, Mehran RJ, Abdalla EK. Improved survival after resection of liver and lung colorectal metastases compared with liver-only metastases: a study of 112 patients with limited lung metastatic disease. J Am Coll Surg 213(1):62-9, 7/2011. PMID: 21700179.
23. Bakaeen FG, Stephens EH, Chu D, Holman WL, Vaporciyan AA, Merrill WH, Grover FL. Perceptions regarding cardiothoracic surgical training at Veterans Affairs hospitals. J Thorac Cardiovasc Surg 141(5):1107-13, 5/2011. e-Pub 3/2011. PMID: 21397273.
24. Stephens EH, Blackmon SH, Correa AM, Roth JA, Rice DC, Hofstetter W, Benjamin R, Mehran R, Swisher SG, Walsh GL, Vaporciyan AA. Progression after chemotherapy is a novel predictor of poor outcomes after pulmonary metastasectomy in sarcoma patients. J Am Coll Surg 212(5):821-6, 5/2011. e-Pub 3/2011. PMID: 21435923.
25. Cleeland CS, Wang XS, Shi Q, Mendoza TR, Wright SL, Berry MD, Malveaux D, Shah PK, Gning I, Hofstetter WL, Putnam JB, Vaporciyan AA. Automated Symptom Alerts Reduce Postoperative Symptom Severity After Cancer Surgery: A Randomized Controlled Clinical Trial. J Clin Oncol 29(8):994-1000, 3/2011. e-Pub 1/2011. PMID: 21282546.
26. Hayashi Y, Correa AM, Hofstetter WL, Vaporciyan AA, Rice DC, Walsh GL, Mehran RJ, Lee JH, Bhutani MS, Dekovich A, Swisher SG, Ajani JA. The influence of high body mass index on the prognosis of patients with esophageal cancer after surgery as primary therapy. Cancer 116(24):5619-27, 12/2010. e-Pub 11/2010. PMID: 21136578.
27. Gaur P, Sepesi B, Hofstetter WL, Correa AM, Bhutani MS, Vaporciyan AA, Watson TJ, Swisher SG, Members of the MD Anderson Esophageal Cancer Group and the University of Rochester School of Medicine and Dentistry Foregut Group. A clinical nomogram predicting pathologic lymph node involvement in esophageal cancer patients. Ann Surg 252(4):611-7, 10/2010. PMID: 20881767.
28. Kountourakis P, Correa AM, Hofstetter WL, Lee JH, Bhutani MS, Rice DC, Komaki R, Maru DM, Ross WA, Vaporciyan A, Swisher SG, Ajani JA. Combined modality therapy of cT2N0M0 esophageal cancer: the University of Texas M. D. Anderson Cancer Center experience. Cancer. e-Pub 10/2010. PMID: 20960497.
29. Mehran R, Rice D, El-Zein R, Huang JL, Vaporciyan A, Goodyear A, Mehta A, Correa A, Walsh G, Roth J, Swisher S, Hofstetter W. Minimally invasive esophagectomy versus open esophagectomy, a symptom assessment study. Dis Esophagus. e-Pub 10/2010. PMID: 21040152.
30. Swisher SG, Hofstetter W, Komaki R, Correa AM, Erasmus J, Lee JH, Liao Z, Maru D, Mehran R, Patel S, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Ajani JA. Improved long-term outcome with chemoradiotherapy strategies in esophageal cancer. Ann Thorac Surg 90(3):892-8; discussion 898-9, 9/2010. PMID: 20732514.
31. Kim MP, Correa AM, Lee J, Rice DC, Roth JA, Mehran RJ, Walsh GL, Ajani JA, Maru DM, Chang JY, Marom EM, Macapinlac HA, Lee JH, Vaporciyan AA, Rice T, Swisher SG, Hofstetter WL. Pathologic T0N1 esophageal cancer after neoadjuvant therapy and surgery: an orphan status. Ann Thorac Surg 90(3):884-90; discussion 890-1, 9/2010. PMID: 20732513.
32. Kim MP, Correa AM, Swisher SG, Hofstetter WL, Mehran RJ, Rice DC, Walsh GL, Erasmus J, Moran C, Vaporciyan AA, Roth JA. Non-small cell lung cancer resection in lymphoma patients. Ann Thorac Surg 90(1):210-6, 7/2010. PMID: 20609777.
33. Vaporciyan A, Reardon MJ. Right heart sarcomas. Methodist Debakey Cardiovasc J 6(3):44-8, Jul-Sep, 7/2010. PMID: 20834211.
34. Gaur P, Hofstetter WL, Bekele BN, Correa AM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Rice TW, Swisher SG. Comparison between established and the Worldwide Esophageal Cancer Collaboration staging systems. Ann Thorac Surg 89(6):1797-1803, 1804.e1-3; discussion 1803-4, 6/2010. PMID: 20494031.
35. Hoang AN, Vaporcyian AA, Matin SF. Laparoscopy-assisted radical nephrectomy with inferior vena caval thrombectomy for level II to III tumor thrombus: a single-institution experience and review of the literature. J Endourol 24(6):1005-12, 6/2010. PMID: 20491594.
36. Harting MT, Lally KP, Andrassy RJ, Vaporciyan AA, Cox CS, Hayes-Jordan A, Blakely ML. Age as a prognostic factor for patients with osteosarcoma: an analysis of 438 patients. J Cancer Res Clin Oncol 136(4):561-70, 4/2010. e-Pub 9/2009. PMID: 19784847.
37. Ajani JA, Correa AM, Walsh GL, Komaki R, Lee JH, Vaporciyan AA, Rice DC, Yao JC, Maru DM, Hofstetter WL, Phan AT, Swisher SG. Trimodality therapy without a platinum compound for localized carcinoma of the esophagus and gastroesophageal junction. Cancer 116(7):1656-63, 4/2010. e-Pub 2/2010. PMID: 20143431.
38. Reed CE, Vaporciyan AA, Erikson C, Dill MJ, Carpenter AJ, Guleserian KJ, Merrill WH. Factors Dominating Choice of Surgical Specialty. J Am Coll Surg 210(3):319-324, 3/2010. PMID: 20193895.
39. Booth JH, Bryant R, Vaporciyan A, Morales DL. Complete lung parenchyma-sparing resection of the right main stem bronchus and bronchus intermedius. J Thorac Cardiovasc Surg 139(1):222-4, 1/2010. e-Pub 3/2009. PMID: 19660315.
40. Braiteh F, Correa AM, Hofstetter WL, Rice DC, Vaporciyan AA, Walsh GL, Roth JA, Mehran RJ, Swisher SG, Ajani JA. Association of age and survival in patients with gastroesophageal cancer undergoing surgery with or without preoperative therapy. Cancer 115(19):4450-8, 10/2009. PMID: 19562780.
41. Bolton WD, Hofstetter WL, Francis AM, Correa AM, Ajani JA, Bhutani MS, Erasmus J, Komaki R, Maru DM, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Swisher SG. Impact of tumor length on long-term survival of pT1 esophageal adenocarcinoma. J Thorac Cardiovasc Surg 138(4):831-6, 10/2009. e-Pub 4/2009. PMID: 19660349.
42. Rice DC, Steliga MA, Stewart J, Eapen G, Jimenez CA, Lee JH, Hofstetter WL, Marom EM, Mehran RJ, Vaporciyan AA, Walsh GL, Swisher SG. Endoscopic ultrasound-guided fine needle aspiration for staging of malignant pleural mesothelioma. Ann Thorac Surg 88(3):862-8; discussion 868-9, 9/2009. PMID: 19699913.
43. Blackmon SH, Shah N, Roth JA, Correa AM, Vaporciyan AA, Rice DC, Hofstetter W, Walsh GL, Benjamin R, Pollock R, Swisher SG, Mehran R. Resection of pulmonary and extrapulmonary sarcomatous metastases is associated with long-term survival. Ann Thorac Surg 88(3):877-84; discussion 884-5, 9/2009. PMID: 19699915.
44. Kassis E, Vaporciyan AA, Swisher S, Correa AM, Bekele BN, Erasmus JJ, Hofstetter WL, Komaki R, Mehran RJ, Moran CA, Pisters KM, Rice DC, Walsh GL, Roth JA. Application of the revised lung cancer staging system (IASLC Staging Project) to a cancer center population. J Thorac Cardiovasc Surg 138(2):412-418, 8/2009. e-Pub 5/28/2009. PMCID: PMC2731793.
45. Bakaeen FG, Jaroszewski DE, Rice DC, Walsh GL, Vaporciyan AA, Swisher SS, Benjamin R, Blackmon S, Reardon MJ. Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era. J Thorac Cardiovasc Surg 137(6):1454-1460, 6/2009. e-Pub 4/2009. PMID: 19464464.
46. Bolton WD, Rice DC, Goodyear A, Correa AM, Erasmus J, Hofstetter W, Komaki R, Mehran R, Pisters K, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Weaver J, Rhines L. Superior sulcus tumors with vertebral body involvement: a multimodality approach. J Thorac Cardiovasc Surg 137(6):1379-1387, 6/2009. PMID: 19464452.
47. Vaporciyan AA, Reed CE, Erikson C, Dill MJ, Carpenter AJ, Guleserian KJ, Merrill W. Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents. Ann Thorac Surg 87(5):1351-1359, 5/2009. PMID: 19379863.
48. Vaporciyan AA, Reed CE, Erikson C, Dill MJ, Carpenter AJ, Guleserian KJ, Merrill W. Factors affecting interest in cardiothoracic surgery: Survey of North American general surgery residents. J Thorac Cardiovasc Surg 137(5):1054-62, 5/2009. PMID: 19379966.
49. Blackmon SH, Rice DC, Correa AM, Mehran R, Putnam JB, Smythe WR, Walkes JC, Walsh GL, Moran C, Singh H, Vaporciyan AA, Reardon M. Management of primary pulmonary artery sarcomas. Ann Thorac Surg 87(3):977-984, 3/2009. PMID: 19231448.
50. Yendamuri S, Swisher SG, Correa AM, Hofstetter W, Ajani JA, Francis A, Maru D, Mehran RJ, Rice DC, Roth JA, Walsh GL, Vaporciyan AA. Esophageal tumor length is independently associated with long-term survival. Cancer 115(3):508-516, 2/1/2009. PMID: 19117343.
51. Cen P, Correa A, Lee JH, Maru D, Anandasabapathy S, Liao Z, Hofstetter WL, Swisher SG, Komaki R, Ross WA, Vaporciyan AA, Ajani JA. Adenocarcinoma of the lower esophagus with barrett's esophagus or without barrett's esophagus: Differences in patients survival after preoperative chemoradiation. Dis Esophagus 22(1):32-41, 2009. e-Pub 11/2008. PMID: 19021684.
52. Yendamuri S, Vaporciyan AA, Zaidi T, Feng L, Fernandez R, Bekele NB, Hofstetter WL, Jiang F, Mehran RJ, Rice DC, Spitz MR, Swisher SG, Walsh GL, Roth JA, Katz RL. 3p22.1 and 10q22.3 deletions detected by fluorescence in situ hybridization (FISH): a potential new tool for early detection of non-small cell lung Cancer (NSCLC). J Thorac Oncol 3(9):979-84, 9/2008. PMID: 18758299.
53. Xing J, Wu X, Vaporciyan AA, Spitz MR, Gu J. Prognostic significance of ataxia-telangiectasia mutated, DNA-dependent protein kinase catalytic subunit, and Ku heterodimeric regulatory complex 86-kD subunit expression in patients with nonsmall cell lung cancer. Cancer 112(12):2756-64, 6/2008. PMID: 18457328.
54. Katz RL, Zaidi TM, Fernandez RL, Zhang J, He W, Acosta C, Daniely M, Madi L, Vargas MA, Dong Q, Jiang XG, Caraway NP, Vaporciyan AA, Roth JA, Spitz MR. Automated detection of genetic abnormalities combined with cytology in sputum is a sensitive predictor of lung cancer. Mod Pathol 21(8):950-60, 5/2008. PMID: 18500269.
55. Bakaeen F, Rice D, Correa AM, Walsh GL, Vaporciyan AA, Putnam JB, Swisher SG, Roth JA, Huh J, Chu D, Smythe WR. Use of aprotinin in extrapleural pneumonectomy: effect on hemostasis and incidence of complications. Ann Thorac Surg 84(3)(3):982-986, 9/2007. PMID: 17720413.
56. Fujitani K, Ajani JA, Crane CH, Feig BW, Pisters PW, Janjan N, Walsh GL, Swisher SG, Vaporciyan AA, Rice D, Welch A, Baker J, Faust J, Mansfield PF. Impact of induction chemotherapy and preoperative chemoradiotherapy on operative morbidity and mortality in patients with locoregional adenocarcinoma of the stomach or gastroesophageal junction. Ann Surg Oncol 14(4):1305-11, 4/2007. PMID: 17253104.
57. Bahna P, Hanna HA, Dvorak T, Vaporciyan AA, Chambers M, Raad I. Antiseptic effect of a novel alcohol-free mouthwash: a convenient prophylactic alternative for high-risk patients. Oral Oncol 43(2):159-64, 2/2007. PMID: 16798063.
58. Yendamuri S, Komaki RR, Correa AM, Allen P, Wynn B, Blackmon S, Hofstetter WL, Rice DC, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Mehran RJ. Comparison of limited surgery and three-dimensional conformal radiation in high-risk patients with stage I non-small cell lung cancer. J Thorac Oncol 2(11):1022-1028, 2007. PMID: 17975494.
59. Rice DC, Smythe WR, Liao Z, Guerrero T, Chang JY, McAleer MF, Jeter MD, Correa A, Vaporciyan AA, Liu HH, Komaki R, Forster KM, Stevens CW. Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma. Int J Radiat Oncol Biol Phys 69(2):350-357, 2007. PMID: 17467922.
60. Rice DC, Stevens CW, Correa AM, Vaporciyan AA, Tsao A, Forster KM, Walsh GL, Swisher SG, Hofstetter WL, Mehran RJ, Roth JA, Liao Z, Smythe WR. Outcomes after extrapleural pneumonectomy and intensity-modulated radiation therapy for malignant pleural mesothelioma. Ann Thorac Surg 84(5):1685-1693, 2007. PMID: 17954086.
61. Blackmon SH, Correa AM, Wynn B, Hofstetter WL, Martin LW, Mehran RJ, Rice DC, Swisher SG, Walsh GL, Roth JA, Vaporciyan AA. Propensity-Matched Analysis of Three Techniques for Intrathoracic Esophagogastric Anastomosis. Ann Thorac Surg 83(5):1805-1813, 2007. PMID: 17462404.
62. Hofstetter W, Correa AM, Bekele N, Ajani JA, Phan A, Komaki RR, Liao Z, Maru D, Wu TT, Mehran RJ, Rice DC, Roth JA, Vaporciyan AA, Walsh GL, Francis A, Blackmon S, Swisher SG. Proposed modification of nodal status in AJCC Esophageal Cancer Staging System. Ann Thorac Surg 84(2):365-375, 2007. PMID: 17643602.
63. Martin LW, Correa AM, Ordonez NG, Roth JA, Swisher SG, Vaporciyan AA, Walsh GL, Rice DC. Sarcomatoid Carcinoma of the lung: A predictor of poor prognosis. Ann Thorac Surg 84(3):973-980, 2007. PMID: 17720411.

Invited Articles
1. Kassis E, Vaporciyan AA. Defining N2 disease in non-small cell lung cancer. Thoracic Surgery Clinics 18(4):333-337, 11/2008.
2. Vaporciyan AA. Getting Cancer information from your doctor. CancerWise, 2007.

Editorials
1. Vaporciyan AA. Isolated lung perfusion, is it time to deal with the 800 pound gorilla? J Surg Oncol 96(7):543-544, 2007. PMID: 17999390.

Book Chapters
1. Kim M, Vaporciyan AA. Pulmonary Resecton. In: ACS Surgery Principles and Practice, 7. Web MD: New York. In Press.
2. Steliga M, Patel A, Vaporciyan AA,. Management of Stage II Non-Small Cell Lung Cancer and Pancoast Tumor. In: Principles and Practice, 4th. Ed(s) Pass HI, Carbone, DP, Minna JD, Johnson DH, Scagliotti GV, Turrisi AT. Lippincott-Williams-Wilkins: USA, 473-489, 2010.
3. Steliga MA, Vaporciyan AA. Surgical Management of Pulmonary Metastases from Osteosarcoma in Pediatric and Adolescent Patients. In: Pediatric and Adolescent Osteosarcoma. Springer: USA, 185-201, 2009.
4. Vaporciyan AA. ACS Surgery: Pulmonary Resection. In: ACS Surgery: Principles and Practice, 6. Ed(s) Souba, W. WebMD: New York, NY, 2007.
5. Vaporciyan AA. Lung Cancer. In: Case Files: General Surgery. McGraw-Hill/Lange Medical Books, In press, 2007.
6. Blackmon SH, Vaporicyan AA. Special Situations: Metastasis (Lung Mets). In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Curley SA, Ross MI, Perrier NE. BC Decker: USA, 720-729, 2007.
7. Herrera LJ, Vaporciyan AA. Surgical Treatment of Squamous Cancer of the Esophagus. In: Advanced Therapy in Surgical Oncology. Ed(s) Pollock RE, Curley SA, Ross MI, Perrier NE. BC Decker: USA, 16-25, 2007.

Last updated: 3/12/2013